References
- BenjaminEJLevyDVaziriSMD’AgostinoRBBelangerAJWolfPAIndependent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart StudyJAMA1994271118408448114238
- KokuboYWatanabeMHigashiyamaANakaoYMKusanoKMiyamotoYDevelopment of a basic risk score for incident atrial fibrillation in a Japanese general population – the Suita StudyCirc J201781111580158828539563
- WangTJPariseHLevyDObesity and the risk of new-onset atrial fibrillationJAMA2004292202471247715562125
- MorinDPBernardMLMadiasCRogersPAThihalolipavanSEstesNA3rdThe state of the art: atrial fibrillation epidemiology, prevention, and treatmentMayo Clin Proc201691121778181027825618
- ColillaSCrowAPetkunWSingerDESimonTLiuXEstimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult populationAm J Cardiol201311281142114723831166
- GoASHylekEMPhillipsKAPrevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) StudyJAMA2001285182370237511343485
- DantasGCThompsonBVMansonJATracyCSUpshurREPatients’ perspectives on taking warfarin: qualitative study in family practiceBMC Fam Pract200451515268764
- SiltariAVapaataloHVascular calcification, vitamin K and warfarin therapy – possible or plausible connection?Basic Clin Pharmacol Toxicol Epub2017621
- MozosIStoianDLucaCTCrosstalk between vitamins A, B12, D, K, C, and E status and arterial stiffnessDis Markers20172017878497128167849
- YamamotoKKoretsuneYAkasakaTEffects of vitamin K antagonist on aortic valve degeneration in non-valvular atrial fibrillation patients: prospective 4-year observational studyThromb Res2017160697529121522
- GrangerCBAlexanderJHMcMurrayJJApixaban versus warfarin in patients with atrial fibrillationN Engl J Med20113651198199221870978
- JanuaryCTWannLSAlpertJS2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm SocietyCirculation2014130232071210424682348
- BarbosaCDBalpMMKulichKGermainNRofailDA literature review to explore the link between treatment satisfaction and adherence, compliance, and persistencePatient Prefer Adherence20126394822272068
- LabaTLEssueBKimmanMJanSUnderstanding patient preferences in medication nonadherence: a review of stated preference dataPatient20158538539525404203
- AttayaSBornsteinTRonquilloNStudy of warfarin patients investigating attitudes toward therapy change (SWITCH Survey)Am J Therap201219643243522198071
- ElewaHFDeRemerCEKellerKGujralJJoshuaTVPatients satisfaction with warfarin and willingness to switch to dabigatran: a patient surveyJ Thromb Thrombolysis201438111512023918529
- OsterbergLBlaschkeTAdherence to medicationN Engl J Med2005353548749716079372
- CanoSJLampingDLBamberLSmithSThe Anti-Clot Treatment Scale (ACTS) in clinical trials: cross-cultural validation in venous thromboembolism patientsHealth Qual Life Outcomes20121012023013426
- WangYKongMCLeeLHNgHJKoYKnowledge, satisfaction, and concerns regarding warfarin therapy and their association with warfarin adherence and anticoagulation controlThromb Res2014133455055424448058
- HanonOChaussadeEGuerangerPGrusonEBonanSGayAPatient-reported treatment satisfaction with rivaroxaban for stroke prevention in atrial fibrillation. A French observational study, the SAFARI StudyPLoS One20161112e016621827935987
- AlexanderJHLopesRDThomasLApixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trialEur Heart J201435422423224144788
- GasparovaIKubatkaPOpatrilovaRPerspectives and challenges of antioxidant therapy for atrial fibrillationNaunyn Schmiedebergs Arch Pharmacol20173901114